Frontotemporal Dementia: PBFT02 Treatment Study

We are evaluating a new treatment for adults with Frontotemporal Dementia linked to GRN or C9orf72 mutations. The study aims to understand its safety and how well it works in this specific group.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Unidade Local De Saude De Coimbra E.P.E.
Servico de Neurologia
Santo António dos Olivais, Portugal
University Hospital Virgen Del Rocio S.L.
UGC Neurology (Memory Unit)
Huelva, Spain
Hospital Universitario Central De Asturias
Neurology
Oviedo, Spain
Sponsor: Passage Bio Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.